Clinically Significant Bacteremia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Clinically Significant Bacteremia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedNot Applicable

NCT02852902

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-…

Main objective: to observationally assess the efficacy and safety of different antimicrobials in BSI due to ESBL or carbapenemase-producing Enterobacterales in…

Spain820 participantsStarted 2016-01-01

CompletedNot Applicable

NCT01764490

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-…

Main objective: to observationally assess the efficacy of different antimicrobials in Bloodstream Infection (BSI) due to Enterobacteriaceae producing ESBLs or c…

Spain1,344 participantsStarted 2013-01